Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ:AMLX
Want to see AMLX full AI Analyst Report?
Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview
8.03% Insiders
23.95% Mutual Funds
47.88% Other Institutional Investors
15.36% ETFs
4.78% Public Companies and
Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 87.19% of the company’s stock is owned by Institutional Investors, 8.03% is owned by Insiders, and 4.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 26, 2026 | xxxxxxxxxxxxx | $51338 | |
Mar 04, 2026 | xxxxxxxxxxxxx | $424003 | |
Mar 04, 2026 | xxxxxxxxxxxxx | $423711 | |
Mar 04, 2026 | xxxxxxxxxxxxx | $99375 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1978470 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $11756620 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $41521343 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,284,882 | Institution | 7.45% | 118,556,661 | |
| 4,961,645 | Institution | 4.46% | 71,001,140 | |
| 4,778,779 | Institution | 4.30% | 68,384,327 | |
| 4,764,684 | Institution | 4.29% | 68,182,628 | |
| 4,410,750 | Institution | 3.97% | 63,117,833 | |
| 4,035,521 | Institution | 3.63% | 57,748,306 | |
| 3,583,548 | Insider | 3.22% | 51,280,572 | |
| 3,583,481 | Insider | 3.22% | 51,279,613 | |
| 3,148,200 | Institution | 2.83% | 45,050,742 | |
| 2,987,147 | Institution | 2.69% | 42,746,074 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,410,750 | Institution | 3.97% | 63,117,833 | |
| 4,035,521 | Institution | 3.63% | 57,748,306 | |
| 3,148,200 | Institution | 2.83% | 45,050,742 | |
| 2,897,375 | Institution | 2.61% | 41,461,436 | |
| 1,512,444 | Institution | 1.36% | 21,643,074 | |
| 1,203,509 | Institution | 1.08% | 17,222,214 | |
| 1,174,309 | Institution | 1.06% | 16,804,362 | |
| 1,085,800 | Institution | 0.98% | 15,537,798 | |
| 1,062,665 | Institution | 0.96% | 15,206,736 | |
| 982,302 | Institution | 0.88% | 14,056,742 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,113,383 | Institution | 2.80% | 49,814,128 | |
| 2,154,902 | Institution | 1.94% | 30,836,648 | |
| 1,171,043 | Institution | 1.05% | 16,804,467 | |
| 1,171,043 | Institution | 1.05% | 16,804,467 | |
| 1,171,043 | Institution | 1.05% | 16,804,467 | |
| 941,050 | Institution | 0.85% | 15,056,800 | |
| 671,975 | Institution | 0.60% | 9,615,962 | |
| 580,040 | Institution | 0.52% | 8,300,372 | |
| 461,837 | Institution | 0.42% | 7,389,392 | |
| 421,118 | Institution | 0.38% | 5,558,758 |
FAQ
Who Owns Amylyx Pharmaceuticals, Inc. (AMLX)?
According to the latest TipRanks data, approximately 47.88% of the company's stock is held by institutional investors, 8.03% is held by insiders, and 4.78% is held by retail investors.
What percentage of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.88% of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by institutional investors.
What percentage of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.78% of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by retail investors.
Who owns the most shares of Amylyx Pharmaceuticals, Inc. (AMLX)?
Joseph Edelman owns the most shares of Amylyx Pharmaceuticals, Inc. (AMLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.